Richard M. Stone

Boston University (US)

Research Areas

Discover Papers by Richard M. Stone

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

133

Publications

1851

Citations

76946

i10-index

590

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Five-Year Follow-up of Patients Receiving Imatinib...	2006	3480
International Consensus Classification of Myeloid ...	2022	2690
Midostaurin plus Chemotherapy for Acute Myeloid Le...	2017	2198
Randomized Controlled Trial of Azacitidine in Pati...	2002	1813
A Tyrosine Kinase Created by Fusion of the <i>PDGF...	2003	1698
Enasidenib in mutant IDH2 relapsed or refractory a...	2017	1469
Durable Remissions with Ivosidenib in <i>IDH1</i> ...	2018	1411
Lenalidomide in the Myelodysplastic Syndrome with ...	2006	1317
Single-Cell RNA-Seq Reveals AML Hierarchies Releva...	2019	1186
International phase 3 study of azacitidine vs conv...	2015	1149

Publications

1.
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Year: 2006Citations: 3480DOI: 10.1056/nejmoa062867
2.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Year: 2022Citations: 2690DOI: 10.1182/blood.2022015850
3.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
Year: 2017Citations: 2198DOI: 10.1056/nejmoa1614359
4.
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
Year: 2002Citations: 1813DOI: 10.1200/jco.2002.04.117
5.
A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Year: 2003Citations: 1698DOI: 10.1056/nejmoa025217
6.
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Year: 2017Citations: 1469DOI: 10.1182/blood-2017-04-779405
7.
Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
Year: 2018Citations: 1411DOI: 10.1056/nejmoa1716984
8.
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Year: 2006Citations: 1317DOI: 10.1056/nejmoa061292
9.
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Year: 2019Citations: 1186DOI: 10.1016/j.cell.2019.01.031
10.
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Year: 2015Citations: 1149DOI: 10.1182/blood-2015-01-621664

About Richard M. Stone

Richard M. Stone is a researcher with 1851 publications and 76946 citations. They are affiliated with Boston University. Their research focuses on . With an h-index of 133, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Richard M. Stone and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year